Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 3 3Phase 1 3Phase NA 2Phase 2/3 2Phase 4 1Phase 1/2 1

Status

Active not recruiting 2Not yet recruiting 1

Sponsor Class

NETWORK 4INDUSTRY 4OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 2Neoplasm Metastasis 1Adenocarcinoma 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × OTHER × luprolide acetate gel depot × Clear all
NCT04302454 2025-04-04

ADOPT

University Medical Center Groningen

Phase 3 Active not recruiting
280 enrolled
Genitourinary

Prostatic Neoplasms

NCT06855589 2025-03-04

PCS-XII

Charles LeMoyne Hospital

Phase 3 Not yet recruiting
400 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT01442246 2024-09-19

Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.

UNICANCER

Phase 3 Active not recruiting
700 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡